| Co-evolution of matrisome and adaptive adhesion dynamics drives ovarian cancer chemoresistance EA Pietilä, J Gonzalez-Molina, L Moyano-Galceran, S Jamalzadeh, ... Nature communications 12 (1), 3904, 2021 | 89 | 2021 |
| Longitudinal single-cell RNA-seq analysis reveals stress-promoted chemoresistance in metastatic ovarian cancer K Zhang, EP Erkan, S Jamalzadeh, J Dai, N Andersson, K Kaipio, ... Science advances 8 (8), eabm1831, 2022 | 77 | 2022 |
| Numerical solution of one-dimensional telegraph equation using cubic B-spline collocation method J Rashidinia, S Jamalzadeh, F Esfahani Journal of Interpolation and Approximation in Scientific Computing 2014, 1-8, 2014 | 29 | 2014 |
| Evolutionary states and trajectories characterized by distinct pathways stratify patients with ovarian high grade serous carcinoma A Lahtinen, K Lavikka, A Virtanen, Y Li, S Jamalzadeh, A Skorda, ... Cancer Cell 41 (6), 1103-1117. e12, 2023 | 15 | 2023 |
| Modified b-spline collocation approach for pricing american style asian options J Rashidinia, S Jamalzadeh Mediterranean Journal of Mathematics 14 (3), 111, 2017 | 11 | 2017 |
| Longitudinal single-cell RNA-seq analysis reveals stress-promoted chemoresistance in metastatic ovarian cancer. Sci. Adv. 8, eabm1831 K Zhang, EP Erkan, S Jamalzadeh, J Dai, N Andersson, K Kaipio, ... | 6 | 2022 |
| QuantISH: RNA in situ hybridization image analysis framework for quantifying cell type-specific target RNA expression and variability S Jamalzadeh, A Häkkinen, N Andersson, K Huhtinen, A Laury, ... Laboratory Investigation 102 (7), 753-761, 2022 | 5 | 2022 |
| Evolutionary states and trajectories characterized by distinct pathways stratify ovarian high-grade serous carcinoma patients A Lahtinen, K Lavikka, Y Li, A Virtanen, S Jamalzadeh, K Huhtinen, ... bioRxiv, 2022.08. 30.505808, 2022 | 3 | 2022 |
| Genome-wide quantification of copy-number aberration impact on gene expression in ovarian high-grade serous carcinoma S Jamalzadeh, J Dai, K Lavikka, Y Li, J Jiang, K Huhtinen, A Virtanen, ... BMC cancer 24 (1), 173, 2024 | 2 | 2024 |
| 776P Multi-omics analysis of chemo-refractory high-grade serous carcinoma patients: Insights from the DECIDER study D Afenteva, TA Muranen, A Rajavuori, S Jamalzadeh, K Zhang, V Ariotta, ... Annals of Oncology 34, S525, 2023 | 1 | 2023 |
| Transcriptome-based characterization of treatment resistance mechanisms in high-grade serous carcinoma S Jamalzadeh Helsingin yliopisto, 2024 | | 2024 |
| Abstract A027: Genome-wide quantification of copy-number aberration impact on gene expression in ovarian high-grade serous carcinoma S Hautaniemi, S Jamalzadeh, J Dai, K Lavikka, Y Li, K Huhtinen, ... Cancer Research 84 (5_Supplement_2), A027-A027, 2024 | | 2024 |
| Genome-wide quantification of copy-number aberration impact on gene expression in ovarian high-grade serous carcinoma S Hautaniemi, S Jamalzadeh, J Dai, K Lavikka, Y Li, K Huhtinen, ... CANCER RESEARCH 84 (5), 2024 | | 2024 |
| Multi-Omics Analysis Reveals the Attenuation of the Interferon Pathway as a Driver of Chemo-Refractory Ovarian Cancer D Afenteva, R Yu, A Rajavuori, M Salvadores, IM Launonen, K Lavikka, ... bioRxiv, 2024.03. 28.587131, 2024 | | 2024 |
| # 252 Evolutionary study identifies poor prognosis HGSC patients and reveals clinically relevant targets at diagnosis and relapse J Oikkonen, A Lahtinen, K Lavikka, A Virtanen, Y Li, S Jamalzadeh, ... International Journal of Gynecologic Cancer 33 (Suppl 3), 2023 | | 2023 |
| # 240 Multi-omics characterization of chemo-refractory high-grade serous cancer TA Muranen, D Afenteva, A Rajavuori, S Jamalzadeh, K Zhang, V Ariotta, ... International Journal of Gynecologic Cancer 33 (Suppl 3), 2023 | | 2023 |
| Multi-omics characterization of chemo-refractory HGSC patients TA Muranen, A Rajavuori, D Afenteva, K Huhtinen, VM Isoviita, ... Cancer Research 83 (7_Supplement), 2135-2135, 2023 | | 2023 |
| Järjestystä munasarjasyövän genomiseen kaaokseen A Lahtinen, K Lavikka, A Virtanen, Y Li, S Jamalzadeh, A Skorda, ... Duodecim 139 (12), 1049, 2023 | | 2023 |
| 582P Longitudinal, multi-sample characterization of HGSC from DECIDER: A Finnish observational study J Oikkonen, A Virtanen, Y Li, VM Isoviita, K Zhang, S Jamalzadeh, ... Annals of Oncology 33, S813, 2022 | | 2022 |
| Integration of clonal composition and tumor heterogeneity reveals novel evolutionary states and intervention targets in ovarian cancer A Lahtinen, K Lavikka, Y Li, S Jamalzadeh, A Virtanen, R Lehtonen, ... CANCER RESEARCH 82 (10), 2022 | | 2022 |
